ALNY Latest Headlines

Alnylam Sets Nov. 18 Webcast at Jefferies Healthcare Conference for 10:00 a.m. GMT

Market Chameleon (Wed, 4-Nov 9:05 AM)

Alnylam Pharmaceuticals authorizes $1B share repurchase program

at seekingalpha.com (Wed, 4-Nov 5:21 PM)

Alnylam downgraded at Truist on Amvuttra outlook

at seekingalpha.com (Mon, 2-Nov 12:31 PM)

Alnylam downgraded at Bernstein on TRITON-CM trial design

at seekingalpha.com (Fri, 30-Oct 10:50 AM)

Piper Sandler Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 30-Oct 7:56 AM)

RBC Capital Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 30-Oct 7:54 AM)

Wells Fargo Remains a Hold on Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 30-Oct 6:36 AM)

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Alnylam Pharma (ALNY) and Illumina (ILMN)

at www.tipranks.com (Fri, 30-Oct 5:50 AM)

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Alnylam Pharma (ALNY) and Tenet Healthcare (THC)

at www.tipranks.com (Fri, 30-Oct 5:10 AM)

Alnylam’s Q3 2026 revenue mix shifts: product sales rose 52% while collaboration revenue fell 80%

Market Chameleon (Thu, 29-Oct 8:38 AM)